(NYSE: ACH) Accendra Health's forecast annual revenue growth rate of 1.64% is not forecast to beat the US Medical Distribution industry's average forecast revenue growth rate of 6.6%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.75%.
Accendra Health's revenue in 2026 is $2,715,928,000.On average, 7 Wall Street analysts forecast ACH's revenue for 2026 to be $199,194,208,902, with the lowest ACH revenue forecast at $190,233,915,768, and the highest ACH revenue forecast at $210,222,261,990. On average, 7 Wall Street analysts forecast ACH's revenue for 2027 to be $207,618,416,122, with the lowest ACH revenue forecast at $192,761,177,934, and the highest ACH revenue forecast at $227,070,676,430.
In 2028, ACH is forecast to generate $218,952,804,018 in revenue, with the lowest revenue forecast at $197,356,200,054 and the highest revenue forecast at $241,315,245,002.